share_log

CVS Health | 3: Initial statement of beneficial ownership of securities-Director ROBBINS LARRY

CVS Health | 3: Initial statement of beneficial ownership of securities-Director ROBBINS LARRY

西維斯健康 | 3:首次持股聲明-董事 ROBBINS LARRY
美股SEC公告 ·  11/26 06:52

Moomoo AI 已提取核心訊息

On 11/17/2024, Larry Robbins, Founder and CEO of Glenview Capital Management, filed an initial statement of beneficial ownership for CVS Health securities. Robbins holds 11,946,799 shares indirectly through Glenview Investment Funds, where he shares voting and dispositive power.Additionally, Robbins holds cash-settled swaps referencing 378,000 shares of CVS Health common stock, also through Glenview Investment Funds. These swaps are exercisable from 08/16/2024 to 09/16/2027. Robbins disclaims beneficial ownership except for any pecuniary interest.This filing, pursuant to Section 16(a) of the Securities Exchange Act of 1934, highlights Robbins' significant stake in CVS Health, reflecting his strategic investment position through Glenview Capital Management.
On 11/17/2024, Larry Robbins, Founder and CEO of Glenview Capital Management, filed an initial statement of beneficial ownership for CVS Health securities. Robbins holds 11,946,799 shares indirectly through Glenview Investment Funds, where he shares voting and dispositive power.Additionally, Robbins holds cash-settled swaps referencing 378,000 shares of CVS Health common stock, also through Glenview Investment Funds. These swaps are exercisable from 08/16/2024 to 09/16/2027. Robbins disclaims beneficial ownership except for any pecuniary interest.This filing, pursuant to Section 16(a) of the Securities Exchange Act of 1934, highlights Robbins' significant stake in CVS Health, reflecting his strategic investment position through Glenview Capital Management.
2024年11月17日,格倫維尤資本管理公司創始人兼首席執行官拉里·羅賓斯提交了CVS Health證券的初步實益所有權聲明。羅賓斯通過格倫維尤投資基金間接持有11,946,799股股票,他在格倫維尤投資基金中擁有投票權和處置權。此外,羅賓斯還通過格倫維尤投資基金持有以現金結算的互換交易,涉及CVS Health的37.8萬股普通股。這些掉期可在2024年8月16日至2027年9月16日期間行使。羅賓斯否認受益所有權,任何金錢利益除外。根據1934年《證券交易法》第16(a)條提交的這份文件重點介紹了羅賓斯在CVS Health的大量股份,反映了他在格倫維尤資本管理公司的戰略投資地位。
2024年11月17日,格倫維尤資本管理公司創始人兼首席執行官拉里·羅賓斯提交了CVS Health證券的初步實益所有權聲明。羅賓斯通過格倫維尤投資基金間接持有11,946,799股股票,他在格倫維尤投資基金中擁有投票權和處置權。此外,羅賓斯還通過格倫維尤投資基金持有以現金結算的互換交易,涉及CVS Health的37.8萬股普通股。這些掉期可在2024年8月16日至2027年9月16日期間行使。羅賓斯否認受益所有權,任何金錢利益除外。根據1934年《證券交易法》第16(a)條提交的這份文件重點介紹了羅賓斯在CVS Health的大量股份,反映了他在格倫維尤資本管理公司的戰略投資地位。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息